Review: taking Mebeverine hydrochloride and Metformin together


Summary

Drug interactions are reported among people who take Mebeverine hydrochloride and Metformin together. This review analyzes the effectiveness and drug interactions between Mebeverine hydrochloride and Metformin. It is created by eHealthMe based on reports of 121 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Mebeverine Hydrochloride

Mebeverine hydrochloride has active ingredients of mebeverine hydrochloride. It is often used in irritable bowel syndrome. (latest outcomes from Mebeverine hydrochloride 453 users)

Metformin

Metformin has active ingredients of metformin hydrochloride. It is often used in diabetes. (latest outcomes from Metformin 174,670 users)

On Sep, 18, 2016

121 people who take Mebeverine Hydrochloride, Metformin are studied.


Number of reports submitted per year:

Mebeverine hydrochloride and Metformin drug interactions.

Drug effectiveness over time:

Mebeverine Hydrochloride:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Metformin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Mebeverine Hydrochloride:
  • female: 0.0% - (0 of 1 people)
  • male: 66.0% - (2 of 3 people)
Metformin:
  • female: 100.0% - (1 of 1 people)
  • male: 100.0% - (2 of 2 people)

Drug effectiveness by age:

Mebeverine Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 50.0% - (1 of 2 people)
Metformin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 100.0% - (2 of 2 people)

Most common drug interactions over time *:

< 1 month:
  • epistaxis
  • rectal haemorrhage
  • encephalopathy
  • hepatic neoplasm malignant
  • hepatitis acute
  • rash pruritic
1 - 6 months:
  • abdominal pain
  • abdominal pain upper
  • diarrhoea
6 - 12 months:
  • glossodynia
  • lip swelling
  • paraesthesia oral
  • swelling face
  • tongue ulceration
1 - 2 years:
  • abdominal pain
  • abdominal pain upper
  • diarrhoea
2 - 5 years:
  • dizziness
  • abdominal pain
  • anaemia haemolytic autoimmune
  • aortic stenosis
  • cardio-respiratory arrest
  • circulatory collapse
  • deep vein thrombosis
  • diarrhoea
  • dyspnoea
  • dysuria
not specified:
  • hypoglycaemia
  • renal failure acute
  • atrial fibrillation
  • vomiting
  • pancreatitis acute
  • pruritus
  • fall
  • cerebral haemorrhage
  • headache
  • cerebrovascular accident

Most common drug interactions by gender *:

female:
  • fall
  • pancreatitis acute
  • vomiting
  • cerebral haemorrhage
  • headache
  • atrial fibrillation
  • cerebrovascular accident
  • defaecation urgency
  • convulsion
  • essential hypertension
male:
  • hypoglycaemia
  • renal failure acute
  • epistaxis
  • rectal haemorrhage
  • encephalopathy
  • erythema
  • hepatic neoplasm malignant
  • angioedema
  • atrioventricular block
  • blister

Most common drug interactions by age *:

20-29:
  • pancreatitis
  • abdominal pain upper
  • frustration
  • hepatic steatosis
  • lipase increased
  • pancreatitis acute
  • weight decreased
30-39:
  • hypoglycaemia
  • renal failure acute
  • urticaria
  • hospitalisation
  • stridor
  • wheezing
  • biopsy liver abnormal
  • choking
  • contrast media reaction
  • dysphagia
40-49:
  • pancreatitis acute
  • cough
  • drug eruption
  • pruritus
  • wheezing
  • hepatic steatosis
  • pain
  • peripheral swelling
  • rash papular
  • weight decreased
50-59:
  • encephalopathy
  • hepatic neoplasm malignant
  • bone pain
  • constipation
  • diarrhoea
  • dyspnoea
  • nausea
  • osteoarthritis
  • pruritus
  • psoriasis
60+:
  • fall
  • atrial fibrillation
  • cerebral haemorrhage
  • vomiting
  • cerebrovascular accident
  • defaecation urgency
  • epistaxis
  • rectal haemorrhage
  • convulsion
  • essential hypertension

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Mebeverine hydrochloride and Metformin?

Can you answer these questions?

More questions for: Mebeverine hydrochloride, Metformin

You may be interested in these reviews

More reviews for: Mebeverine hydrochloride, Metformin

On eHealthMe, Mebeverine hydrochloride (mebeverine hydrochloride) is often used to treat irritable bowel syndrome. Metformin (metformin hydrochloride) is often used to treat diabetes. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.